Ebola virus vaccine (Profectus Biosciences)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameEbola virus vaccine (Profectus Biosciences)
Drug Alias NameVesiculoVax Zaire-Ebola virusVesiculoVax-vectored Ebola virus vaccineMonovalent vesicular stomatitis virus vectored Ebola virus vaccinerVSVN4CT1-EBOVGP1
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAuro Vaccines Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAuro Vaccines Llc
Active IndicationsN/A
Inactive IndicationsHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A